DuPont Co. saw seed sales rise in the second quarter—good news before it closes in on the historic $75 billion merger with Dow Chemical Co., the parent of Indianapolis-based Dow AgroSciences.
The grant from the Indianapolis-based philanthropic giant is aimed at bolstering Indiana’s stature as a life sciences research hub.
The 16 Tech innovation district, an ambitious economic development project in the works in Indianapolis for more than a decade, has hired a top executive whose goal is to turn the downtrodden area into a thriving center for entrepreneurship and innovation.
Around Indiana, hospitals are doubling down on the lofty goal of patient satisfaction. Some, like IU Health, are hiring managers to oversee various aspects of the patient experience, from registration to discharge.
Bio-Response Solution’s flagship product liquefies human corpses, turning muscle, flesh and fat into a coffee-colored effluent that can be swirled down the drain.
Indiana’s Management Performance Hub is organizing and analyzing data to help state agencies make better decisions about fighting the opioid scourge and other systemic problems.
LifeOmic is seeking to help doctors provide more precise treatments for patients by sequencing their DNA.
Leigh Ann Pusey will join Eli Lilly and Co. next month as senior vice president for corporate affairs and communications.
Founded in 2006, Fast BioMedical Inc. plans to use the money to help advance clinical trials and hire additional workers. It develops technologies to measure blood volume and kidney function.
Around Indiana, life sciences companies are searching high and low for venture capital to fund promising but expensive new products, which can take a decade or longer to develop.
Safis Solutions LLC, a 15-year-old Indianapolis consulting firm that helps life science companies move their products through the government regulatory process, has been acquired by PharmaLex, the companies announced Monday.
When Dow AgroSciences needed to battle a proposed federal ban on one of its most important products, it drafted an army—its farmers.
The federal agency says the Indianapolis doctor studying Pfizer’s Chantix last year failed to keep accurate records and used patients who didn’t meet the trial requirements.
Indianapolis-based software company Greenlight.guru has moved operations from one downtown facility to another to accommodate expansion.
Rainer Fischer’s goal is to spur collaboration in research and commercialization of life sciences products.
Freedom Healthworks, which expects to serve 12 physician practices with 6,000 patients by the end of the year, is relocating from Nora to downtown and tripling its office space.
Fishers-based Recovery Force LLC took a big step this month toward its goal of bringing to market a wrap that’s designed to improve blood flow and enhance recovery for people battling serious health issues.
Purdue University Professor You-Yeon Won’s development, called radio-luminescent nanoparticles, is designed to enhance the cancer-cell-killing effects of radiation treatment.
Gov.-elect Eric Holcomb, who announced his legislative agenda Thursday, has roughly the same idea as Gov. Mike Pence when it comes to investing in early-stage Indiana companies, but wants to pay for the plan through a different fund.
The company’s announcement reassured investors in the wake of last month’s news that the Alzheimer’s drug solanezumab had failed to demonstrate effectiveness during a large-scale clinical trial.
